- Report
- February 2026
- 549 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 476 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 274 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 271 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 384 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 185 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 273 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 193 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- February 2026
- 267 Pages
Global
From €5124EUR$5,850USD£4,447GBP
- Report
- May 2025
- 110 Pages
Global
From €4160EUR$4,750USD£3,611GBP
- Report
- June 2025
- 400 Pages
Global
From €4334EUR$4,949USD£3,762GBP
- Report
- November 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- October 2025
- 160 Pages
Global
From €3459EUR$3,950USD£3,003GBP
- Report
- September 2025
- 150 Pages
Global
From €3372EUR$3,850USD£2,927GBP
€4248EUR$4,850USD£3,687GBP
- Report
- July 2025
- 215 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Report
- May 2025
- 165 Pages
Global
From €4248EUR$4,850USD£3,687GBP
- Report
- August 2025
- 200 Pages
United States
From €2181EUR$2,490USD£1,893GBP
- Report
- December 2025
- 200 Pages
United States
From €2181EUR$2,490USD£1,893GBP
- Report
- April 2025
- 83 Pages
United States
From €3065EUR$3,500USD£2,661GBP

The Neurotech market is a subset of the Neurology Devices industry, focusing on the development and commercialization of products and services related to the diagnosis, treatment, and management of neurological disorders. Neurotech products range from medical devices such as brain-computer interfaces, deep brain stimulation systems, and neuroprosthetics, to software and digital health solutions such as brain-computer interfaces, virtual reality, and artificial intelligence. Neurotech companies are also developing novel treatments for neurological disorders, such as gene therapy, stem cell therapy, and gene editing.
The Neurotech market is driven by advances in technology, increasing prevalence of neurological disorders, and growing demand for personalized treatments. Neurotech companies are also leveraging the power of data to develop more effective treatments and improve patient outcomes.
Notable companies in the Neurotech market include NeuroPace, NeuroMetrix, BrainScope, NeuroSigma, NeuroVista, and NeuroSens. Show Less Read more